Dapagliflozin and sacubitril on myocardial microperfusion in patients with post-acute myocardial infarction heart failure and type 2 diabetes

Table 3 Comparison of blood glucose indicators between the two groups

Item	Control group (n = 47)		t	P value	Observation group (n = 51)		t	P value
	Before treatment	After treatment			Before treatment	After treatment
FBG (mmol/L)	11.12 ± 1.77	7.47 ± 1.08a	12.89	< 0.01	10.98 ± 1.84	6.33 ± 0.87a,c	16.23	< 0.01
2hPG (mmol/L)	15.21 ± 2.56	10.41 ± 2.01a	12.16	< 0.01	15.34 ± 2.17	8.41 ± 1.81a,c	16.20	< 0.01
HbA1c (%)	12.25 ± 2.74	8.02 ± 1.96a	12.16	< 0.01	11.98 ± 2.83	6.84 ± 1.54a,c	13.31	< 0.01

^aP < 0.05 vs before treatment.

^cP < 0.05 vs control group.

FBG: Fasting blood glucose; 2hPG: 2-h postprandial glucose; HbA1c: Glycated hemoglobin.